0000000000011531

AUTHOR

Alberto Zanchetti

0000-0003-4796-7959

showing 23 related works from this author

European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring

2014

Given the increasing use of ambulatory blood pressure monitoring (ABPM) in both clinical practice and hypertension research, a group of scientists, participating in the European Society of Hypertension Working Group on blood pressure monitoring and cardiovascular variability, in year 2013 published a comprehensive position paper dealing with all aspects of the technique, based on the available scientific evidence for ABPM. The present work represents an updated schematic summary of the most important aspects related to the use of ABPM in daily practice, and is aimed at providing recommendations for proper use of this technique in a clinical setting by both specialists and practicing physici…

AdultMalemedicine.medical_specialtyAmbulatory blood pressureAdolescentPhysiologyMEDLINEPharmacyWhite coat hypertensionPractice PatternsBlood Pressure MonitoringMasked HypertensionAtrial FibrillationAmbulatoryInternal MedicinemedicineHumansambulatory blood pressure monitoring arterial hypertension clinic blood pressure measurement clinical indications guidelines home blood pressure measurement practice recommendationsObesityPractice Patterns Physicians'ChildIntensive care medicineReimbursementPhysicians'business.industryMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREBlood Pressure Monitoring Ambulatorymedicine.disease3. Good healthMasked HypertensionBlood pressureHypertensionPosition paperFemaleCardiology and Cardiovascular MedicinebusinessSoftwareWhite Coat HypertensionJournal of Hypertension
researchProduct

Riskard 2005. New tools for prediction of cardiovascular disease risk derived from Italian population studies.

2005

Abstract Background and aim The need to update tools for the estimate of cardiovascular risk prompted the “Gruppo di Ricerca per la Stima del Rischio Cardiovascolare in Italia” to produce a new chart and new software called Riskard 2005. Methods and results Data from 9 population studies in 8 Italian regions, for a grand total of 17,153 subjects (12,045 men and 5,108 women) aged 35–74 and for a total exposure of about 194,000 person/years were available. A chart for the estimate of cardiovascular risk (major coronary, cerebrovascular and peripheral artery disease events) in 10 years was produced for men and women aged 45–74 free from cardiovascular diseases. Risk factors employed in the est…

AdultMaleRiskmedicine.medical_specialtyEndocrinology Diabetes and MetabolismPopulationMedicine (miscellaneous)Risk AssessmentDiabetes ComplicationsSex FactorsPredictive Value of TestsRisk FactorsSoftware DesignPrevalenceMedicineHumansRisk factoreducationAgededucation.field_of_studyNutrition and DieteticsFramingham Risk Scorebusiness.industrySmokingAbsolute risk reductionAge FactorsMiddle AgedSurgeryRisk EstimateCholesterolItalyCardiovascular DiseasesRelative riskHypertensionFemaleCardiology and Cardiovascular MedicinebusinessRisk assessmentBody mass indexAlgorithmsDemographyFollow-Up StudiesNutrition, metabolism, and cardiovascular diseases : NMCD
researchProduct

2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardio…

2013

1. INTRODUCTION1.1 PrinciplesThe 2013 European Society of Hypertension/European Society of Cardiology (ESH/ESC) guidelines continue to adhere to some fundamental principles that inspired the 2003 and 2007 guidelines, namely to base recommendations on properly conducted studies identified from an ext

medicine.medical_specialtyArterieKidney DiseasePrognosiPhysiologyCardiologyBlood PressureGuidelineRisk AssessmentDevice therapyRisk FactorsInternal medicineAntihypertensive treatmentInternal MedicineMedicineHumansIntensive care medicineLife StyleAntihypertensive Agentsbusiness.industryTask forceRisk FactorCardiovascular complicationOrgan damageArteriesCardiovascular riskLifestylePrognosisOrgan damageDevice therapyAntihypertensive AgentBlood pressureHypertensionCardiologyKidney DiseasesbusinessCardiology and Cardiovascular MedicineHumanJournal of hypertension
researchProduct

Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence.

2014

BACKGROUND AND OBJECTIVES:: It is well established by a large number of randomized controlled trials that lowering blood pressure (BP) and low-density lipoprotein cholesterol (LDL-C) by drugs are powerful means to reduce stroke incidence, but the optimal BP and LDL-C levels to be achieved are largely uncertain. Concerning BP targets, two hypotheses are being confronted: first, the lower the BP, the better the treatment outcome, and second, the hypothesis that too low BP values are accompanied by a lower benefit and even higher risk. It is also unknown whether BP lowering and LDL-C lowering have additive beneficial effects for the primary and secondary prevention of stroke, and whether these…

Malemedicine.medical_specialtyPhysiologyHypercholesterolemiaLow density lipoprotein cholesterolBlood Pressurelaw.inventionCognitionRandomized controlled triallawRecurrenceInternal medicineblood pressure cognitive decline low-density lipoprotein cholesterol primary prevention secondary prevention strokeInternal MedicineSecondary PreventionMedicineHumansCognitive declineStrokeBeneficial effectsRandomized Controlled Trials as TopicSecondary preventionbusiness.industryMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLARECholesterol LDLmedicine.diseasePrimary PreventionStrokeBlood pressureCholesterolCardiologyPhysical therapylipids (amino acids peptides and proteins)Cardiology and Cardiovascular MedicinebusinessStroke incidenceCognition Disordersblood pressure; cognitive decline; low-density lipoprotein cholesterol; primary prevention; secondary prevention; strokeJournal of hypertension
researchProduct

Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive tre…

2016

medicine.medical_specialtyPhysiologybusiness.industry030204 cardiovascular system & hematologymedicine.disease03 medical and health sciences0302 clinical medicineBlood pressureSprintShot (pellet)Internal MedicinePhysical therapyMedicine030212 general & internal medicineCardiology and Cardiovascular MedicinebusinessStrokeJournal of hypertension
researchProduct

Guía de práctica clínica de la ESH/ESC para el manejo de la hipertensión arterial (2013)

2013

Gynecologymedicine.medical_specialtyPresión arterialRiesgo cardiovascularbusiness.industryHTATratamiento con dispositivoDeterminación de la presión arterialSeguimientoPalabras claveEstilo de vidaDaño orgánicoComplicaciones cardiovasculareInternal MedicinemedicineCardiology and Cardiovascular MedicinebusinessTratamiento antihipertensivoGuíaRevista Española de Cardiología
researchProduct

Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient : design of the Euro…

2014

BACKGROUND AND OBJECTIVES:: The SBP values to be achieved by antihypertensive therapy in order to maximize reduction of cardiovascular outcomes are unknown; neither is it clear whether in patients with a previous cardiovascular event, the optimal values are lower than in the low-to-moderate risk hypertensive patients, or a more cautious blood pressure (BP) reduction should be obtained. Because of the uncertainty whether 'the lower the better' or the 'J-curve' hypothesis is correct, the European Society of Hypertension and the Chinese Hypertension League have promoted a randomized trial comparing antihypertensive treatment strategies aiming at three different SBP targets in hypertensive pati…

Malemedicine.medical_specialtyChinaPhysiologyBlood Pressurelaw.inventionchemistry.chemical_compoundCognitionRandomized controlled triallawRecurrenceInternal medicineInternal MedicinemedicineSecondary Preventionblood pressure; cognitive decline; low-density lipoprotein cholesterol; randomized controlled trial; secondary prevention; strokeDementiaHumansProspective StudiesCognitive declineProspective cohort studyStrokeAntihypertensive AgentsAgedLdl cholesterolCholesterolbusiness.industryBlood Pressure DeterminationCholesterol LDLlipoprotein cholesterol randomized controlled trial secondary prevention strokeMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREmedicine.diseaseblood pressure cognitive decline low-densityEuropeStrokeBlood pressurechemistryIschemic Attack TransientHypertensionPhysical therapyCardiologyDementiaHydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicinebusinessCognition Disorders
researchProduct

2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension

2018

International audience; These practice guidelines on the management of arterial hypertension are a concise summary of the more extensive ones prepared by the Task Force jointly appointed by the European Society of Hypertension and the European Society of Cardiology. These guidelines have been prepared on the basis of the best available evidence on all issues deserving recommendations; their role must be educational and not prescriptive or coercive for the management of individual subjects who may differ widely in their personal, medical and cultural characteristics. The members of the Task Force have participated independently in the preparation of these guidelines, drawing on their academi…

Malemedicine.medical_specialtyblood pressure measurementAdvisory Committees030204 cardiovascular system & hematologycombination therapyPotential conflict03 medical and health sciences0302 clinical medicineDevice therapyInternal medicineLifestyle interventionsecondary hypertensionInternal MedicineHumansMedicinedevice therapyadherence030212 general & internal medicineSocieties MedicalComputingMilieux_MISCELLANEOUSlifestyle interventionshypertension-mediated organ damageTask forcebusiness.industryGeneral Medicinespecial conditionsdrug therapy3. Good healthEuropeHypertensionBlood pressureCardiologyFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieCardiology and Cardiovascular Medicinebusinessblood pressure treatment thresholds and targets
researchProduct

Issues in the development of new combinations of blood pressure lowering drugs

2010

medicine.medical_specialtyPharmacotherapyBlood pressurePhysiologybusiness.industryAnesthesiaInternal MedicinemedicineBlood pressure loweringCardiology and Cardiovascular MedicinebusinessSurgeryJournal of Hypertension
researchProduct

Agreement within Europe about antihypertensive treatment and education – results from the European Society of Hypertension questionnaire

2010

medicine.medical_specialtyPediatricsPhysiologybusiness.industrymedia_common.quotation_subjectMEDLINEAgreementEuropeFamily medicineHypertensionPractice Guidelines as TopicInternal MedicinemedicineHumansMulticenter Studies as TopicCardiology and Cardiovascular MedicinebusinessAntihypertensive Agentsmedia_commonJournal of Hypertension
researchProduct

Target blood pressure in elderly hypertensive patients and in patients with diabetes mellitus

2014

Aged 80 and overmedicine.medical_specialtyPhysiologybusiness.industryDiabetes MellituBlood PressureMiddle Agedmedicine.diseaseBlood pressureInternal medicineDiabetes mellitusHypertensionPractice Guidelines as TopicDiabetes MellitusInternal MedicineHumansMedicineIn patientCardiology and Cardiovascular MedicinebusinessHumanAgedJournal of Hypertension
researchProduct

Methodology and technology for peripheral and central blood pressure and blood pressure variability measurement: current status and future directions…

2016

Office blood pressure measurement has been the basis for hypertension evaluation for almost a century. However, the evaluation of blood pressure out of the office using ambulatory or self-home monitoring is now strongly recommended for the accurate diagnosis in many, if not all, cases with suspected hypertension. Moreover, there is evidence that the variability of blood pressure might offer prognostic information that is independent of the average blood pressure level. Recently, advancement in technology has provided noninvasive evaluation of central (aortic) blood pressure, which might have attributes that are additive to the conventional brachial blood pressure measurement. This position …

Position statementmedicine.medical_specialtyAmbulatory blood pressurePhysiologycentral blood pressureBlood Pressureclinic blood pressure030204 cardiovascular system & hematologylaw.inventionperipheral blood pressure03 medical and health sciences0302 clinical medicineCentral blood pressurelawaortic blood pressuremedicineInternal MedicineHumansBlood pressure monitoring030212 general & internal medicineIntensive care medicineambulatory blood pressureSocieties Medicalbrachial blood pressurebusiness.industryself-measurementMedicine (all)Blood Pressure DeterminationPeripheralEuropemonitoringPressure measurementBlood pressurePractice Guidelines as TopicAmbulatoryblood pressure variabilitymeasurementbusinessCardiology and Cardiovascular Medicine
researchProduct

2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension

2013

ABPMambulatory blood pressure monitoringACEangiotensin converting enzymeARBangiotensin receptor blockerA-Vatrio-ventricularBBbeta-blockerBPblood pressureCHDcoronary heart diseaseCKDchronic kidney d...

medicine.medical_specialtyKidneybusiness.industryMEDLINEGeneral MedicineBlood pressuremedicine.anatomical_structureFamily medicineInternal MedicinemedicineHypertension diagnosisCardiology and Cardiovascular MedicineIntensive care medicinebusinessBlood Pressure
researchProduct

MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled tr…

2018

Introduction Masked uncontrolled hypertension (MUCH) carries an increased risk of cardiovascular (CV) complications and can be identified through combined use of office (O) and ambulatory (A) blood pressure (BP) monitoring (M) in treated patients. However, it is still debated whether the information carried by ABPM should be considered for MUCH management. Aim of the MASked-unconTrolled hypERtension management based on OBP or on ambulatory blood pressure measurement (MASTER) Study is to assess the impact on outcome of MUCH management based on OBPM or ABPM. Methods and analysis MASTER is a 4-year prospective, randomised, open-label, blinded-endpoint investigation. A total of 1240 treated hyp…

HYPERTENSION MANAGEMENTHipertensión.1302masked uncontrolled hypertensionEnfermedades cardiovasculares - Pacientes - Factores de riesgo.office blood pressureMASKED UNCONTROLLED HYPERTENSIONMedicina ClínicaCardiovascular Medicine030204 cardiovascular system & hematologyAMBULATORY BLOOD PRESSURE MONITORINGlaw.invention0302 clinical medicineClinical trialsRandomized controlled triallawBlood Pressure MonitoringMasked Hypertension//purl.org/becyt/ford/3.2 [https]ProtocolMulticenter Studies as Topic1506030212 general & internal medicineCardiovascular system - Diseases - Patients - Risk factors.Blood pressure.OFFICE BLOOD PRESSURERandomized Controlled Trials as TopicSistemas Cardíaco y CardiovascularGeneral MedicineBlood Pressure Monitoring Ambulatory3. Good healthCor MalaltiesEchocardiographyAmbulatoryHypertensionBlood pressure//purl.org/becyt/ford/3 [https]Hipertensióambulatory blood pressure monitoring; hypertension; hypertension management; masked uncontrolled hypertension; office blood pressure; treated hypertensive patientsTREATED HYPERTENSIVE PATIENTS1683medicine.medical_specialtyAmbulatory blood pressureCIENCIAS MÉDICAS Y DE LA SALUDhypertensionHeart Ventriclestreated hypertensive patientPressió sanguínia03 medical and health sciencesAmbulatoryHypertension.medicineAlbuminuriaHumansAntihypertensive AgentsProtocol (science)business.industryConsolidated Standards of Reporting Trialsambulatory blood pressure monitoring; hypertension; hypertension management; masked uncontrolled hypertension; office blood pressure; treated hypertensive patients; Albuminuria; Antihypertensive Agents; Echocardiography; Heart Ventricles; Humans; Masked Hypertension; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Blood Pressure Monitoring Ambulatorytreated hypertensive patientsambulatory blood pressure monitoringBlood pressurePresión sanguínea.Good clinical practiceEmergency medicinebusinessDeclaration of Helsinkihypertension managementAssaigs clínicsBMJ Open
researchProduct

Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension.

2009

Hypertension in children and adolescents has been gaining ground in cardiovascular medicine, mainly due to the advances made in several areas of pathophysiological and clinical research. These guidelines arose from the consensus reached by specialists in the detection and control of hypertension in children and adolescents. Furthermore, these guidelines are a compendium of scientific data and the extensive clinical experience it contains represents the most complete information that doctors, nurses and families should take into account when making decisions. These guidelines, which stress the importance of hypertension in children and adolescents, and its contribution to the current epidemi…

medicine.medical_specialtyAdolescentPhysiologyMEDLINEPublic policyDiseasechildrenRisk FactorsGuidelines.EpidemiologyInternal MedicineMedicineHumansBlood pressure monitoringIntensive care medicineChildLife StyleClinical Trials as Topicbusiness.industryInfantBlood Pressure DeterminationBlood Pressure Monitoring AmbulatoryBlood pressureClinical researchFamily medicineHypertension complicationsChild PreschoolHypertensionMED/09 - MEDICINA INTERNACardiology and Cardiovascular MedicinebusinessGoalsAlgorithmsBP controlJournal of hypertension
researchProduct

Manejo de la hipertensión arterial en niños y adolescentes: recomendaciones de la Sociedad Europea de Hipertensión

2010

Resumen: La hipertensión en niños y adolescentes ha ido ganando terreno en la medicina cardiovascular, gracias a los avances producidos en distintas áreas de la investigación fisiopatológica y clínica. Estas guías nacen del consenso al que han llegado los especialistas en la detección y control de la hipertensión en niños y adolescentes. Por otra parte, dichas guías son un compendio de los datos científicos y la extensa experiencia clínica con la que se cuenta, y constituyen la información clínica más completa que los médicos, enfermeras y familiares deberían tener en cuenta a la hora de tomar decisiones. Estas guías, que hacen hincapié en la importancia de la hipertensión en niños y adoles…

medicine.medical_specialtybusiness.industryEarly detectionRecommendationsAdolescentsPediatricsRJ1-570Clinical researchHigh blood pressureHigh pressureFamily medicinePediatrics Perinatology and Child HealthInternal MedicineMedicineCardiology and Cardiovascular MedicinebusinessChildrenEuropean Society of hypertensionHipertensión y Riesgo Vascular
researchProduct

Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document

2009

Abbreviations ACE: angiotensin-converting enzyme; BP: blood pressure; DBP: diastolic blood pressure; eGFR: estimated glomerular filtration rate; ESC: European Society of Cardiology; ESH: European Society of Hypertension; ET: endothelin; IMT: carotid intima-media thickness; JNC: Joint National Commit

medicine.medical_specialtymanagement arterial hypertensionPhysiologyupdateRenal functionBlood PressureInternal medicinemedicineInternal MedicineHumanscardiovascular diseasesAntihypertensive AgentsTask forcebusiness.industryHypertension GuidelineHypertension managementGeneral MedicineEuropeOrgan damageBlood pressureHypertensionPractice Guidelines as Topiccardiovascular systemCardiologyMED/09 - MEDICINA INTERNAbusinessEndothelin receptorCardiology and Cardiovascular Medicine
researchProduct

Clinical Perspective on Antihypertensive Drug Treatment in Adults With Grade 1 Hypertension and Low-to-Moderate Cardiovascular Risk:An International …

2017

Hypertension is a leading risk factor for disease burden globally. An unresolved question is whether grade 1 hypertension (140-159/90-99. mm. Hg) with low (cardiovascular mortality <1% at 10 years) to moderate (cardiovascular mortality ≥1% and <5% at 10 years) absolute total cardiovascular risk (CVR) should be treated with antihypertensive agents. A virtual international consultation process was undertaken to summarize the opinions of select experts. After holistic analysis of all epidemiological, clinical, psychosocial, and public health elements, this consultation process reached the following consensus in hypertensive adults aged <80 years: (1) The question of whether drug treat…

AdultMaleRiskmedicine.medical_specialtyPediatricsEvidence-based practiceHeart Diseasesmedicine.drug_classMEDLINE030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineHypertension/complicationsEpidemiologymedicineHumans030212 general & internal medicineRisk factorAntihypertensive drugAntihypertensive AgentsDisease burdenAntihypertensive Agents/therapeutic usebusiness.industryPublic healthHeart Diseases/etiologyGeneral MedicineHypertensionFemaleCardiology and Cardiovascular MedicinebusinessPsychosocial
researchProduct

Association of central and peripheral pulse pressure with intermediate cardiovascular phenoytpes

2012

Objective: We assessed the relationship between pulse pressure and intermediate cardiovascular phenotypes in a middle-aged cohort with high prevalence of hypertension. Background: It has been suggested that central pulse pressure (cPP) is a better predictor of cardiovascular outcome than peripheral pulse pressure (pPP), particularly in the elderly. Yet, it is unclear if cPP provides additional prognostic information to pPP in younger individuals. Methods: In 535 individuals we assessed cPP and pPP as well as the intermediate cardiovascular phenotypes pulse wave velocity (PWV; SphygmoCor, Complior, PulsePen), carotid intima-media thickness (C-IMT; carotid ultrasound), left-ventricular mass i…

MalePhysiologyintermediate cardiovascular phenotypesBlood Pressure030204 cardiovascular system & hematologysurrogate markersCohort Studiespressure0302 clinical medicineHeart Ratepulse wave analysis030212 general & internal medicinerisk-factorsstage renal-diseasePulse wave velocitypulse wave analysiMiddle AgedPhenotypePeripheralPulse pressureleft ventricular hypertrophyarterial stiffnessPhenotypeaortic pressureAortic pressureCardiologyall-cause mortalityFemaleCardiology and Cardiovascular MedicineHumanAdultmedicine.medical_specialtyMean arterial pressurehypertensioncollaborative trial acctpulse wave velocityhypertension; intermediate cardiovascular phenotypes; intimamedia thickness; left ventricular hypertrophy; pressure; pulse wave analysis; pulse wave velocity; Adult; Cohort Studies; Female; Humans; Hypertension; Male; Middle Aged; Phenotype; Blood Pressure; Heart Rate; Internal Medicine; Physiology; Cardiology and Cardiovascular Medicinebrachial blood-pressurewave reflectionsteady component03 medical and health sciencesintermediate cardiovascular phenotypeInternal medicineHeart ratemedicineInternal MedicineHumansintima-media thicknessintimamedia thicknebusiness.industrymedicine.diseaseintimamedia thicknessBlood pressureIntima-media thicknessArterial stiffnessCohort Studiebusiness
researchProduct

European society of hypertension position paper on ambulatory blood pressure monitoring

2013

Ambulatory blood pressure monitoring (ABPM) is being used increasingly in both clinical practice and hypertension research. Although there are many guidelines that emphasize the indications for ABPM, there is no comprehensive guideline dealing with all aspects of the technique. It was agreed at a consensus meeting on ABPM in Milan in 2011 that the 34 attendees should prepare a comprehensive position paper on the scientific evidence for ABPM.This position paper considers the historical background, the advantages and limitations of ABPM, the threshold levels for practice, and the cost-effectiveness of the technique. It examines the need for selecting an appropriate device, the accuracy of dev…

Arterial hypertensionmedicine.medical_specialtyAmbulatory blood pressurePhysiologyMEDLINEWhite coat hypertension030204 cardiovascular system & hematologylaw.invention03 medical and health sciencesresearch application0302 clinical medicineRandomized controlled triallawInternal Medicinemedicine030212 general & internal medicineguidelinesIntensive care medicineambulatory blood pressure monitoring clinic blood pressure measurement clinical indications guidelines home blood pressure measurement recommendations research applicationReimbursementbusiness.industryGuidelinemedicine.diseasehome blood pressure measurement3. Good healthMasked Hypertensionambulatory blood pressure monitoringrecommendationsPosition paperclinic blood pressure measurementCardiology and Cardiovascular Medicinebusinessclinical indications
researchProduct

2013 ESH/ESC Guidelines for the management of arterial hypertension

2013

Because of new evidence on several diagnostic and therapeutic aspects of hypertension, the present guidelines differ in many respects from the previous ones. Some of the most important differences are listed below: 1. Epidemiological data on hypertension and BP control in Europe. 2. Strengthening of the prognostic value of home blood pressure monitoring (HBPM) and of its role for diagnosis and management of hypertension, next to ambulatory blood pressure monitoring (ABPM). 3. Update of the prognostic significance of night-time BP, white-coat hypertension and masked hypertension. 4. Re-emphasis on integration of BP, cardiovascular (CV) risk factors, asymptomatic organ damage (OD) and clinica…

Maleblood pressure measurementPhysiologyEnfermedad cardiovascularWhite coat hypertensionLeft ventricular hypertrophyEpidemiologyfollow-upguidelinesblood pressureGeneral MedicineMiddle AgedEuropeOrgan damageRenal sympathetic denervationCardiologyFemaleCardiology and Cardiovascular MedicineRisk assessmentAdultcardiovascular risklifestylemedicine.medical_specialtyhypertensionAmbulatory blood pressureorgan damagecardiovascular complicationsCardiologíaPrehypertensionantihypertensive treatmentYoung AdultDevice therapyInternal medicineHipertensiónInternal MedicinemedicineHumansdevice therapyLife StyleAntihypertensive AgentsSistema cardiovascularAgedTask forcebusiness.industryta3121medicine.diseaseMasked HypertensionBlood pressureIntima-media thicknessbusinessJournal of Hypertension
researchProduct

2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents.

2016

Increasing prevalence of hypertension (HTN) in children and adolescents has become a significant public health issue driving a considerable amount of research. Aspects discussed in this document include advances in the definition of HTN in 16 year or older, clinical significance of isolated systolic HTN in youth, the importance of out of office and central blood pressure measurement, new risk factors for HTN, methods to assess vascular phenotypes, clustering of cardiovascular risk factors and treatment strategies among others. The recommendations of the present document synthesize a considerable amount of scientific data and clinical experience and represent the best clinical wisdom upon wh…

Gerontologymedicine.medical_specialtyAdolescentPhysiologyCardiovascular risk factorsPublic policyBlood PressureDiseaseComorbidity030204 cardiovascular system & hematologyKlinikai orvostudományokEuropeanManagement of high blood pressure03 medical and health sciences0302 clinical medicineCentral blood pressureRisk Factors030225 pediatricsmedicineInternal MedicinePrevalenceHumansClinical significancecardiovascular diseasesIntensive care medicineChildChildrenSociety of hypertensionCentral blood pressureAntihypertensive AgentsOut of office blood pressurebusiness.industryPublic healthRisk FactorBlood Pressure DeterminationOrvostudományokRecommendationmedicine.diseaseComorbidity3. Good healthAntihypertensive AgentBlood pressureHypertensionbusinessCardiology and Cardiovascular MedicineHumanJournal of hypertension
researchProduct

European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the second international consensus conference …

2008

This document summarizes the available evidence and provides recommendations on the use of home blood pressure monitoring in clinical practice and in research. It updates the previous recommendations on the same topic issued in year 2000. The main topics addressed include the methodology of home blood pressure monitoring, its diagnostic and therapeutic thresholds, its clinical applications in hypertension, with specific reference to special populations, and its applications in research. The final section deals with the problems related to the implementation of these recommendations in clinical practice. ispartof: Journal of Hypertension vol:26 issue:8 pages:1505-1530 ispartof: location:Neth…

medicine.medical_specialtySpecial populationsPhysiologybusiness.industryMEDLINEConsensus conferenceMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREBlood Pressure Monitoring Ambulatoryguidelinesarterial hypertension cardiovascular risk home blood pressure monitoringClinical PracticeEuropeHypertensionInternal MedicinemedicineHumansBlood pressure monitoringHypertension diagnosisDrug MonitoringCardiology and Cardiovascular MedicineIntensive care medicinebusinessAntihypertensive Agents
researchProduct